Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Radioimmunotherapy with 131 I-Rituximab: What We Know and What We Don't Know

Cancer Biotherapy and Radiopharmaceuticals

Impact Factor: 1.7 / 5-Year Impact Factor: 2.4

Journal Homepage Submission guidelines

Restricted access

Editorial

First published online August, 2003

Radioimmunotherapy with 131 I-Rituximab: What We Know and What We Don't Know

Volume 18, Issue 4

https://doi.org/10.1089/108497803322287565

Abstract

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer

Retricted access

Use of FDG PET/CT in Patients with Pancoast Tumors: Does It Add Any Contribution to Patient Management?

Retricted access

The Synthetic Parasite-Derived Peptide GK1 Increases Survival in a Preclinical Mouse Melanoma Model

Retricted access

Winners' Cup: A National Football Tournament Brings Together Adolescent Patients with Cancer from all over Italy